Lushang Freda Pharmaceutical Co., Ltd. Class ASSE: 600223

"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Notice on Convening the 2nd Extraordinary General Meeting in 2026

Aug 26, 2026 · Issued by Lushang Freda Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Notice on Convening the 2nd Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Lushang Freda Pharmaceutical Co., Ltd. Class A

"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Announcement on Signing of the Financial Services Agreement with Shandong Commercial Group Finance Co., Ltd. and Related Party TransactionsAug 15
"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Announcement on Progress in Transfer of Certain Company Shares under Agreement by Controlling Shareholder and Changes in Equity InterestsAug 12
"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Indicative Announcement on Agreement-based Transfer of Certain Company Shares by Controlling Shareholder and Changes in Equity InterestsAug 7
"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Announcement on Implementation of Dividend Distribution for 2025Jul 7

All Lushang Freda Pharmaceutical Co., Ltd. Class A news releases